Press release -
Extended deadline for Scientific Papers on Coeliac Disease
The Association of European Coeliac Societies (AOECS) announce an extended deadline for submissions to its third call for scientific papers. Researchers and innovators working on coeliac disease are now invited to submit their abstracts by September 23, 2024. Accepted submissions will be featured as scientific posters during the AOECS Annual Conference in Madrid, taking place from November 14 to 17, 2024.
AOECS continues to prioritize the advancement of coeliac disease research and public awareness. This call for papers offers a platform for researchers to present groundbreaking findings in areas such as gluten-free diets, early diagnosis, patient quality of life, and innovative treatment options.
Since 1988, AOECS National Coeliac Societies have convened yearly to discuss critical issues related to coeliac disease and to hold our General Assembly. As of 2022, the conference also includes the compilation of new and interesting research into a Scientific Book, which serves as a resource for both the coeliac community and scientific professionals.
We encourage research groups conducting or planning studies on coeliac disease, as well as AOECS members, to take this opportunity to contribute to the global discourse on coeliac disease and its treatments. Your participation can help shape the future of coeliac disease research and improve the lives of those affected.
For submission details and guidelines, please visit our website or contact us directly at press@aoecs.org.
Related links
Categories
The Association of European Coeliac Societies (AOECS) is an independent, non-profit umbrella organisation of over 40 member and affiliated National Coeliac Societies. Together with our members, we represent people affected by coeliac disease or dermatitis herpetiformis across Europe and beyond.
We are involved in several international initiatives to raise awareness of coeliac disease, gluten free diets, and encourage research into coeliac disease early diagnosis, patient’s quality of life and cure.
